                                                   5
         Abstract
         Medicine intermediates sulfanilic acid synthesis method, comprises the following
   steps: 3mol 4-aminophenol, 4-5mol 2-sulfonic acid toluene and 10-16g aluminum
 5 chloride powder are added to the reaction vessel, and the temperature of the solution
   is raised to 90-110 0C, after the addition is complete, and the temperature is kept for
   80-120min, reduce the solution temperature to 10-15 C, adding 2L potassium bromide
   solution, crystals precipitated, filter it, the crystal dissolved in potassium carbonate
   solution, reduce the solution temperature to 5-8 C, crystals precipitated, filter out the
10 crystal, washed with bromine chloride solution, and with triethylamine solution, and
   with nitromethane solution, dehydrated with dehydrating agent, drying at 110-115 'C,
   finally get product sulfanilic acid.

                                                    1
                      Medicine intermediates sulfanilic acid synthesis method
         FIELD OF THE INVENTION
         The present invention relates to medicine intermediates sulfanilic acid synthesis
 5 method.
         GENERAL BACKGROUND
         Sulfanilic acid is mainly used for organic synthesis of pharmaceuticals,
   brighteners, pesticides and other intermediates, however, most of the existing synthetic
10 methods are complicated and the final yield is not very high. Therefore, it is necessary
   to propose a new synthetic method for further improving the quality and yield of the
   product and reducing the byproduct content, it has important economic significance.
         SUMMARY
15       The purpose of the present invention is to provide medicine intermediates
   sulfanilic acid synthesis method, comprises the following steps:
         (i) 3mol 4-aminophenol, 4-5mol 2-sulfonic acid toluene and 10-16g aluminum
   chloride powder are added to the reaction vessel, and the temperature of the solution is
   raised to 90-110 C, after the addition is complete, and the temperature is kept for
20 80-120min, reduce the solution temperature to 10-15 C, adding 2L potassium bromide
   solution, crystals precipitated, filter it, the crystal dissolved in potassium carbonate
   solution, reduce the solution temperature to 5-8 C, crystals precipitated, filter out the
   crystal, washed with bromine chloride solution, and with triethylamine solution, and
   with nitromethane solution, dehydrated with dehydrating agent, drying at 110-115 0C,
25 finally get product sulfanilic acid; wherein, the mass fraction of potassium carbonate
   solution in the step (i) is 30-36%, the mass fraction of the potassium bromide solution
   in the step (i) is 10-17%, the mass fraction of the triethylamine solution in the step (i) is
   50-55%, the mass of the nitromethane solution in the step (i) is 65-70%, the
   dehydrating agent in step (i) is any one of solid sodium hydroxide and anhydrous
30 magnesium sulfate.

                                                    2
          Throughout the reaction process can be the following reaction formula:
             CH3                   NH2                NH2           CH3
                    S03H                      AlC 3                        OH
                                   OH                 S03 H
          Advantage of the present invention is that: reducing intermediate links reaction,
    decreasing the reaction time and improving the reaction yield.
2 5
          DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
          The following examples with reference to specific embodiments of the present
    invention are further illustrated:
          medicine intermediates sulfanilic acid synthesis method.
 10
          Embodiment 1
          3 mol 4-aminophenol, 4 mol 2-sulfotoluene and 10 g aluminum chloride powder
    were added to the reaction vessel, after the addition, the temperature ofthe solution was
    increased to 90C and kept for 80 min, lowering the solution temperature to 104C,
 15 adding 2L potassium bromide solution with a mass fraction of 10%, crystals
    precipitated, filter it, the crystal was dissolved in 30% potassium carbonate solution,
    the temperature of the solution was reduced to 5'C, the crystal was separated out, and
    the crystal was filtered out, washed with potassium bromide solution with a mass
    fraction of 10%, and washed with the triethylamine solution with a mass fraction of
 20 50%, washed with the nitromethane solution with a mass fraction of 65%, dehydrated
    with solid sodium hydroxide dehydration, drying at 110 0C, finally get product
    sulfanific acid 461.91 g, yield 89%.
          Embodiment 2
 25       3 mol 4-aminophenol, 4.5 mnol2-sulfonic acid toluene and 13 g aluminum chloride
    powder were added to the reaction vessel, after the addition, the temperature of the
    solution was raised to 100 0C and kept for 100 min, lowering the solution temperature

                                                   3
   to 12'C, adding 2L potassium bromide solution with a mass fraction of 13%, crystals
   precipitated, filter it, the crystal was dissolved in 33% potassium carbonate solution,
   and the temperature of the solution was reduced to 6 'C, the crystal was precipitated
   and the crystal was filtered out, washed with potassium bromide solution with a mass
 5 fraction of 13%, and with triethylamine solution the mass fraction of 52%, and with
   nitromethane solution with a mass fraction of 67%, dehydrated with anhydrous
   magnesium sulfate dehydration, drying at 112 'C, finally get product sulfanilic acid
   477.48 g, yield 92%.
10       Embodiment 3
         3 mol 4-aminophenol, 5 mol 2-sulfonic acid toluene and 16 g aluminum chloride
   powder were added to the reaction vessel, after the addition, the temperature of the
   solution was increased to 110 'C and kept for 120 min, reduced the solution
   temperature to 15 'C, adding 2L potassium bromide solution with a mass fraction of
15 17%, crystals precipitated, filter it, the crystal was dissolved in 36% potassium
   carbonate solution and the temperature of the solution was reduced to 8 'C, the
   crystal was precipitated and the crystal was filtered out, washed with potassium
   bromide solution with a mass fraction of 17%, and with triethylamine solution with a
   mass fraction of 55%, washed with nitromethane solution with a mass fraction of 70%,
20 dehydrated with solid sodium hydroxide dehydration, drying at 115"C, finally get
   product sulfanilic acid 487.86 g, yield 94%.

                                                  4
         Claims
         1. Medicine intermediates sulfanilic acid synthesis method, comprises the
   following steps:
         (i) 3mol 4-aminophenol, 4-5mol 2-sulfonic acid toluene and 10-16g aluminum
 5 chloride powder are added to the reaction vessel, and the temperature of the solution
   is raised to 90-110 C, after the addition is complete, and the temperature is kept for
   80-120min , reduce the solution temperature to 10-15 C, adding 2L potassium
   bromide solution, crystals precipitated, filter it, the crystal dissolved in potassium
   carbonate solution, reduce the solution temperature to 5-8 0 C, crystals precipitated,
10 filter out the crystal, washed with bromine chloride solution, and with triethylamine
   solution, and with nitromethane solution, dehydrated with dehydrating agent, drying
   at 110-115     C, finally get product sulfanilic acid; wherein, the mass fraction of
   potassium carbonate solution in the step (i) is 30-36%, the mass fraction of the
   potassium bromide solution in the step (i) is 10-17%, the mass fraction of the
15 triethylamine solution in the step (i) is 50-55%.
         2. Medicine intermediates sulfanilic acid synthesis method according to claim 1
   wherein the mass of the nitromethane solution in the step (i) is 65-70%.
20       3. Medicine intermediates sulfanilic acid synthesis method according to claim 1
   wherein the dehydrating agent in step (i) is any one of solid sodium hydroxide and
   anhydrous magnesium sulfate.

